Showing results (71-80 of 273) with videos related to
Sort By:
Pageof 28
Cells|November 23, 2019
Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem CellsStefano Thellung, Alessandro Corsaro, Alessia G Bosio, et al.Frontiers in Endocrinology|May 3, 2021
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?Sergio Di Molfetta, Andrea Dotto, Giuseppe Fanciulli, et al.Bio-Protocol|February 12, 2026
Simple and Rapid Model to Generate Differentiated Endometrial Floating OrganoidsAdriana Bajetto, Alessandra Pattarozzi, Alessandro Corsaro, et al.Cell Cycle (Georgetown, Tex.)|January 18, 2013
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary culturesElisa Carra, Federica Barbieri, Daniela Marubbi, et al.Neuro-Oncology|April 11, 2018
Sprouty2 enhances the tumorigenic potential of glioblastoma cellsJong-Whi Park, Guido Wollmann, Carles Urbiola, et al.Cancer Genetics and Cytogenetics|January 22, 2004
Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical courseSilvia Viaggi, Angelo Abbondandolo, Massimo Carbone, et al.International Journal of Molecular Sciences|November 9, 2024
Ruta graveolens, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma CellsIolanda Camerino, Paola Franco, Adriana Bajetto, et al.Cells|December 23, 2022
Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer TreatmentGiorgia Ailuno, Alice Balboni, Gabriele Caviglioli, et al.Annals of the New York Academy of Sciences|December 18, 2002
Proteasome inhibitors induce cerebellar granule cell death: inhibition of nuclear factor-kB activationCarola Porcile, Patrizia Piccioli, Sabrina Stanzione, et al.Hematological Oncology|December 1, 2007
The presence of high-risk chromosome aberrations in chronic lymphocytic leukaemia does not correlate with centrosome aberrationsLaura Ottaggio, Annalisa Zunino, Irena Maric, et al.Pageof 28